OXAVITA S.R.L.

Oxavita S.R.L. specializes in portable hyperbaric chambers, such as the Revitalair model. These devices are designed for controlled oxygen therapy and are intended for use in both clinical and home settings, offering a compact and mobile solution for therapeutic applications.

Oxavita S.R.L. is headquartered in the United States. The company’s location influences its regulatory compliance and market focus, particularly in regions where its devices are authorized for use.

Oxavita S.R.L.’s devices, including portable hyperbaric chambers like Revitalair, are listed in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify medical devices authorized for commercial distribution in the U.S.

Oxavita S.R.L.’s hyperbaric chambers, such as the Revitalair model, fall under FDA Class II classification. This classification typically applies to devices that pose moderate risk and require special controls—such as performance standards or post-market surveillance—to ensure safety and effectiveness.